Evidence map›Paper›PMID 39168993›Full record

ArticleTranslational psychiatry2024

Actomyosin-mediated inhibition of synaptic vesicle release under CB

Maureen H McFadden, Michel-Boris Emeritt, Hao Xu, Yihui Cui, Christophe Leterrier, Diana Zala, Laurent Venance, Zsolt Lenkei

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Translational psychiatry, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Maureen H McFadden *Institut Pasteur, Université Paris Cité, Synapse and Circuit Dynamics Laboratory, CNRS UMR 3571, Paris, France.
Michel-Boris Emeritt *Institute of Psychiatry and Neuroscience of Paris (IPNP), Université Paris Cité, INSERM U1266, Paris, France.
Hao Xu *Dynamics and Pathophysiology of Neuronal Networks Team, Center for Interdisciplinary Research in Biology (CIRB), Collège de France, CNRS, INSERM, Université PSL, Paris, France.
Yihui CuiDynamics and Pathophysiology of Neuronal Networks Team, Center for Interdisciplinary Research in Biology (CIRB), Collège de France, CNRS, INSERM, Université PSL, Paris, France.
Christophe LeterrierNeuroCyto, Aix Marseille Université, CNRS, INP UMR 7051, Marseille, France.
Diana ZalaBrain Plasticity Unit, ESPCI Paris, PSL Research University, CNRS, Paris, France.
Laurent VenanceDynamics and Pathophysiology of Neuronal Networks Team, Center for Interdisciplinary Research in Biology (CIRB), Collège de France, CNRS, INSERM, Université PSL, Paris, France.
Zsolt LenkeiBrain Plasticity Unit, ESPCI Paris, PSL Research University, CNRS, Paris, France. zsolt.lenkei@inserm.fr.ORCID 0000-0002-1142-5931

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Long-term synaptic plasticity is critical for adaptive function of the brain, but presynaptic mechanisms of functional plasticity remain poorly understood. Here, we show that changes in synaptic efficacy induced by activation of the cannabinoid type-1 receptor (CB

Indexed as

ActomyosinNeuronal PlasticityPresynaptic TerminalsReceptor, Cannabinoid, CB1rho-Associated KinasesSynaptic VesiclesAnimalsMaleMiceMyosin Type IIRatsActomyosinMyosin Type IIReceptor, Cannabinoid, CB1rho-Associated Kinases

Identifiers

PMID39168993
PMCPMC11339458

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.